Global Consortium, Inc. has received
approval from FINRA for
change the Name and Ticker effective
tomorrow
-
The new ticker will be GCGX
-
The Name will be changed to Global
Consortium, Inc.
Coconut Creek,
FL -- December
20, 2018 --
InvestorsHub NewsWire -- Global Consortium, Inc., (OTCPINK:
BDCI) is pleased to
announce effective tomorrow morning the Name change and Ticker
change will take effect.
The process was
longer than we thought, but in the end we were able to supply the
necessary documents to effect the Name and Ticker
change.
Today the Name and
Ticker change will show on the Daily List provided by
FINRA.
The Name and Ticker
are the first of many changes planned for Global Consortium, Inc.
as we bring the Company to the next level.
Lots of updates will
be coming in the first quarter of the New Year as Manufacturing
comes online January 1, 2019 and THC edibles come online later in
the quarter.
The company's
partner ToMaRa
received
word this week they did not receive a license in West Hollywood for
Retail or Consumption. Only 8 of the 300 applicants received
licenses, none of the
existing dispensaries received a license including
MedMen.
This is not a setback
for the Company since when
we filed
the application the direction of the business has changed to
Manufacturing. The facility in California will generate
considerably more
money than the Retail or Consumption site would have, with less
overheard and no employee issues.
Global Consortium
will not seek anymore Retail licenses and focus on building out the
building and expanding the brands under its umbrella.
Global Consortium,
Inc., in compliance with
SEC regulations, may in the future use social media outlets like
Facebook or Twitter and its own website to announce key information
in compliance with Reg. FD.
Forward-Looking
Statements
This news release
contains "forward-looking statements" as that term is defined in
Section 27(a) of the United States Securities Act of 1933, as
amended and Section 21(e) of the Securities Exchange Act of 1934,
as amended. Statements in this press release which are not purely
historical are forward-looking statements and include any
statements regarding beliefs, plans, expectations or intentions
regarding the future. Such forward-looking statements include,
among other things, estimates
of services and equipment markets, release of corporate apps,
growth of platform, target markets, product releases, product
demand and, business strategy. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among
others, the inherent uncertainties associated with new projects and
development stage companies. These forward-looking statements are
made as of the date of this news
release, and we assume no obligation to update the forward-looking
statements, or to update the reasons why actual results could
differ from those projected in the forward-looking statements.
Although we believe that any beliefs, plans, expectations and
intentions contained in this press release are reasonable, there
can be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all
of the information set forth herein and should also consider that
any investment in securities is at risk.
Details
of the Company's business, finances, appointments and agreements
can be found as part of the Company's continuous public disclosure
on otcmarkets.com.
For additional
information about this release please contact:
Investor
Relations:
Matt Dwyer
matt@cannabisconsortium.net
www.cannabisconsortium.net
Twitter: @CannabisConsort
954-906-0098